These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Intermittent vs continuous levodopa administration in patients with advanced Parkinson disease: a clinical and pharmacokinetic study. Stocchi F; Vacca L; Ruggieri S; Olanow CW Arch Neurol; 2005 Jun; 62(6):905-10. PubMed ID: 15956161 [TBL] [Abstract][Full Text] [Related]
6. Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson's disease. Nyholm D Expert Rev Neurother; 2006 Oct; 6(10):1403-11. PubMed ID: 17078781 [TBL] [Abstract][Full Text] [Related]
7. Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion. Meiler B; Andrich J; Müller T Mov Disord; 2008 Jan; 23(1):145-6. PubMed ID: 17987653 [TBL] [Abstract][Full Text] [Related]
8. Clinical experience with duodenal infusions of levodopa for the treatment of motor fluctuations in Parkinson's disease. Sage JI; Sonsalla PK; McHale DM; Heikkila RE; Duvoisin RC Adv Neurol; 1990; 53():383-6. PubMed ID: 2122646 [No Abstract] [Full Text] [Related]
9. [Treatment of Parkinson disease with levodopa depot preparations]. Larsen JP; Nessler EG; Hestnes A; Vilming S; Holmsen R; Aksnes V; Johnson S; Brodtkorb E; Hunstad NA; Helle JR Tidsskr Nor Laegeforen; 1991 Oct; 111(26):3163-6. PubMed ID: 1948939 [TBL] [Abstract][Full Text] [Related]
10. Impaired absorption of oral levodopa: a major cause for response fluctuations in Parkinson's disease. Djaldetti R; Ziv I; Melamed E Isr J Med Sci; 1996 Dec; 32(12):1224-7. PubMed ID: 9007159 [TBL] [Abstract][Full Text] [Related]
11. Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease. Antonini A; Mancini F; Canesi M; Zangaglia R; Isaias IU; Manfredi L; Pacchetti C; Zibetti M; Natuzzi F; Lopiano L; Nappi G; Pezzoli G Neurodegener Dis; 2008; 5(3-4):244-6. PubMed ID: 18322402 [TBL] [Abstract][Full Text] [Related]
12. Irregular gastrointestinal drug absorption in Parkinson's disease. Nyholm D; Lennernäs H Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):193-203. PubMed ID: 18248312 [TBL] [Abstract][Full Text] [Related]
13. Treating motor fluctuations with controlled-release levodopa preparations. Koller WC; Pahwa R Neurology; 1994 Jul; 44(7 Suppl 6):S23-8. PubMed ID: 8047257 [TBL] [Abstract][Full Text] [Related]
14. [Continuous treatment with levodopa of Parkinson disease]. Lundqvist C; Nystedt T; Reiertsen O; Grotli R; Beiske AG Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2638-40. PubMed ID: 16215609 [TBL] [Abstract][Full Text] [Related]
15. Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome. Antonini A; Isaias IU; Canesi M; Zibetti M; Mancini F; Manfredi L; Dal Fante M; Lopiano L; Pezzoli G Mov Disord; 2007 Jun; 22(8):1145-9. PubMed ID: 17661426 [TBL] [Abstract][Full Text] [Related]
16. Comparison of apomorphine and levodopa infusions in four patients with Parkinson's disease with symptom fluctuations. Nyholm D; Constantinescu R; Holmberg B; Dizdar N; Askmark H Acta Neurol Scand; 2009 May; 119(5):345-8. PubMed ID: 18822087 [TBL] [Abstract][Full Text] [Related]